Inventor · Cambridge, MA, US

Stephane Bancel

32Patents
17h-index
22Co-inventors
77Inventor score

Filing activity: Aug 5, 2011 → Jun 30, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US8822663B2 Engineered nucleic acids and methods of use thereof Human Necessities 331 Active
US8710200B2 Engineered nucleic acids encoding a modified erythropoietin and their expression Chemistry; Metallurgy 286 Active
US8999380B2 Modified polynucleotides for the production of biologics and proteins associated with human disease Emerging Cross-Sectional Technologies 177 Active
US9464124B2 Engineered nucleic acids and methods of use thereof Chemistry; Metallurgy 159 Active
US9597380B2 Terminally modified RNA Chemistry; Metallurgy 125 Active
US9254311B2 Modified polynucleotides for the production of proteins Chemistry; Metallurgy 100 Active
US9221891B2 In vivo production of proteins Chemistry; Metallurgy 98 Active
US9675668B2 Modified polynucleotides encoding hepatitis A virus cellular receptor 2 Emerging Cross-Sectional Technologies 96 Active
US9428535B2 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof Chemistry; Metallurgy 84 Active
US9181319B2 Engineered nucleic acids and methods of use thereof Human Necessities 81 Active
US9572896B2 In vivo production of proteins Chemistry; Metallurgy 65 Active
US9587003B2 Modified polynucleotides for the production of oncology-related proteins and peptides Chemistry; Metallurgy 59 Active
US9572897B2 Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins Chemistry; Metallurgy 52 Active
US9504734B2 Modified polynucleotides for the production of nuclear proteins Chemistry; Metallurgy 50 Active
US10772975B2 Modified Polynucleotides for the production of biologics and proteins associated with human disease Emerging Cross-Sectional Technologies 34 Active
US10925935B2 Terminally Modified RNA Chemistry; Metallurgy 17 Active
US9878056B2 Modified polynucleotides for the production of cosmetic proteins and peptides Chemistry; Metallurgy 17 Active
US9814760B2 Modified polynucleotides for the production of biologics and proteins associated with human disease Emerging Cross-Sectional Technologies 14 Active
US9447164B2 Engineered nucleic acids and methods of use thereof Human Necessities 13 Active
US10155029B2 Terminally modified RNA Chemistry; Metallurgy 10 Active
US10858647B2 Removal of DNA fragments in mRNA production process Chemistry; Metallurgy 7 Active
US9827332B2 Modified polynucleotides for the production of proteins Chemistry; Metallurgy 6 Active
US9782462B2 Modified polynucleotides for the production of proteins associated with human disease Chemistry; Metallurgy 6 Active
US10138507B2 Manufacturing methods for production of RNA transcripts Chemistry; Metallurgy 5 Active
US11377470B2 Ribonucleic acid purification Chemistry; Metallurgy 2 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.